DEO Signs Commercial Agreement with DePuy Synthes, Part of Johnson & Johnson

Genk, Belgium, June 24, 2021 – Health tech company DEO (Data-Driven Efficiency for the Operating RoomTM) is proud to announce the signing of a commercial agreement with DePuy Synthes, part of the Johnson & Johnson Medical Device Companies, one of the world’s largest manufacturers of healthcare products.

To safeguard the healthcare infrastructure as we know it, this agreement is now more relevant than ever. Hospitals urgently need comprehensive data insights to optimize existing processes, material, and technology usage, especially in the operating room (OR).

DEO’s data and services platform provide such insights, enabling hospitals to implement seamless OR planning, make informed change decisions and predict the impact of new technology implementations.

Consequently, objective evidence, combined with the sharing of best practices, can potentially reduce waiting times, speed up innovation to market and ultimately let hospitals reap the benefits of technology faster.

The commercial agreement makes it possible for DEO and DePuy Synthes to combine their expertise to benefit hospitals, care teams, and patients and allows DePuy Synthes to offer the DEO Solution to their customers.

Jeroen Dille, founder and CEO of DEO, says, “We’re extremely proud of this collaboration with one of the leading medical device companies. We’re looking very much forward to be working together with DePuy Synthes and bring data-driven efficiency to hospitals in the EMEA region.”

About DEO

DEO—headquartered in Genk, Belgium—has developed an innovative Operating Room Efficiency Platform that supports hospitals in reducing fatigue among surgical teams, increasing patient volume, and improving financial performance. Through a data-driven approach, DEO generates local efficiency and ergonomics data inside the operating room and implements best-in-class processes and technology for efficient care delivery.

About DePuy Synthes

DePuy Synthes, the Orthopedics Company of Johnson & Johnson, provides one of the most comprehensive orthopedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit

Press contact

Jeroen Dille, Founder and CEO,, +32 468 29 04 92

Add Comment